TL1A HLE
/ Vial
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 26, 2025
A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis
(clinicaltrials.gov)
- P1 | N=34 | Recruiting | Sponsor: Battery Bio Australia Pty Ltd | N=54 ➔ 34
Enrollment change • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
June 20, 2025
A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis
(clinicaltrials.gov)
- P1 | N=54 | Recruiting | Sponsor: Battery Bio Australia Pty Ltd
New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
1 to 2
Of
2
Go to page
1